#Cannabis Products #Financial Growth #Curaleaf Holdings

Curaleaf Report: Strong Performance in Q4 and Full Year 2025

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a leading figure in the cannabis industry, recently released its financial results for the fourth quarter and totality of the year for 2025. The numbers speak volumes about the company's trajectory, highlighting both domestic and international growth alongside improved gross margins.

Financial Performance Overview

In the fourth quarter of 2025, Curaleaf boasted a net revenue of $333 million, marking a slight increase of 5% from the previous quarter and a 2% rise year-over-year. This steady revenue boost reflects the company's resilience in a challenging market, where price competition remains intense. On the international front, the company reported a remarkable $51 million in revenue for Q4, which represents a substantial growth of 10% sequentially and 65% year-on-year.

A key highlight from the report was the adjusted gross margin, which rose to 49%, benefiting from enhanced productivity in cultivation that mitigated the effects of pricing pressures. For the entire year, Curaleaf recorded total revenues of approximately $1.27 billion, with an adjusted gross margin of 50% and adjusted EBITDA reaching $275 million.

Strategic Advances

Boris Jordan, the Chairman and CEO of Curaleaf, emphasized the company’s promising position, noting that they concluded 2025 with significant momentum. Following a strategic $500 million debt offering that paved the way for growth, Curaleaf is set on accelerating its operations under its